Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bolt Biotherapeutics (BOLT) Other Operating Expenses (2024)

Bolt Biotherapeutics (BOLT) has disclosed Other Operating Expenses for 1 consecutive years, with $1.5 million as the latest value for Q4 2024.

  • Quarterly Other Operating Expenses changed N/A to $1.5 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Sep 2025, changed N/A year-over-year, with the annual reading at $1.5 million for FY2024, N/A changed from the prior year.
  • Other Operating Expenses hit $1.5 million in Q4 2024 for Bolt Biotherapeutics.
  • In the past five years, Other Operating Expenses ranged from a high of $1.5 million in Q4 2024 to a low of $1.5 million in Q4 2024.